We have collected information about Transnasal Pulmonary Aerosol Delivery for you. Follow the links to find out details on Transnasal Pulmonary Aerosol Delivery.
http://parion.com/pipeline/tpad/
t PAD (Trans nasal Pulmonary Aerosol Delivery) Respiratory Disease Overview. Breathing provides us with the oxygen we need to survive, but also exposes us to pathogens and other hazardous particles. To protect our bodies, the lungs possess an elegant system to remove harmful particles from the airways, known as mucociliary clearance.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597746/
Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial. Jie Li, # 1 Jian Luo, # 2 Yibing Chen, # 3 Lixing Xie, 3 and James B Fink 1, 4Author: Jie Li, Jian Luo, Yibing Chen, Lixing Xie, James B Fink
https://clinicaltrials.gov/ct2/show/NCT03739359
Nov 13, 2018 · The Role of Gas Flow in Transnasal Pulmonary Aerosol Delivery: A Double-blinded, Randomized Controlled Trial. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it …
https://bmjopen.bmj.com/content/9/6/e028584
Jun 01, 2019 · Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trialAuthor: Jie Li, Jian Luo, Yibing Chen, Lixing Xie, James B Fink
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564034/
Aug 01, 2017 · Because slow, continuous delivery of short-acting agents could improve safety, tolerability, compliance, and efficacy when compared with the rapid, intermittent aerosol treatments delivered by mouthpiece or mask, a novel trans-nasal pulmonary aerosol delivery (tPAD) …Author: Kirby L. Zeman, Juan Rojas Balcazar, Fred Fuller, Karl H. Donn, Richard C. Boucher, William D. Benne...
http://rc.rcjournal.com/content/62/6/662
Jun 01, 2017 · Inhaled medications are the mainstay of therapy for many pediatric pulmonary diseases. Device and delivery technique selection is key to improving lung deposition of inhaled drugs. This paper will review the subject in relationship to several pediatric clinical situations: acute pediatric asthma, transnasal aerosol delivery, delivery through tracheostomies, and delivery during noninvasive and ...Author: Ariel Berlinski
Searching for Transnasal Pulmonary Aerosol Delivery?
You can just click the links above. The data is collected for you.
